Amgen Inc. (1AMGN)
MTA
376.65
+9.85 (+2.69%)
Closed
Aug 21, 2026
Day's Range
370.25376.65
52 wk Range
230.90376.65
Financial Statements - 1AMGN - Amgen Inc.
Revenue
36.75B▲ 29.8%
Net Income
7.71B▲ 122.5%Net Margin 21.0%
EBITDA
16.89B▲ 49.3%
Free Cash Flow
8.10B▼ 8.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 36.75B | 28.31B | 28.19B | 26.32B | 25.97B | 25.42B |
| Cost of Goods | 12.03B | 10.89B | 8.45B | 6.40B | 6.45B | 6.15B |
| Gross Profit | 24.71B | 17.42B | 19.73B | 19.91B | 19.52B | 19.26B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.08B | 6.14B | 7.89B | 9.56B | 9.14B | 9.13B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2.65B | 428.67M | 2.83B | -814M | -1.24B | 256M |
| Pre Tax Income | 8.97B | 3.90B | 7.85B | 7.34B | 6.70B | 8.13B |
| Income Tax | 1.26B | 439.68M | 1.13B | 794M | 808M | 869M |
| Net Income | 7.71B | 3.46B | 6.71B | 6.55B | 5.89B | 7.26B |
| EPS Basic | 14.33 | 7.62 | 12.56 | 12.18 | 10.34 | 12.4 |
| EPS Diluted | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 | 12.31 |
| Basic Shares Outstanding | 538M | 454.93M | 556.78M | 559.90M | 593.21M | 609.86M |
| Diluted Shares Outstanding | 538M | 454.93M | 556.78M | 559.90M | 593.21M | 609.86M |
| Ebit | 11.73B | 6.57B | 10.73B | 8.75B | 7.89B | 9.39B |
| Ebitda | 16.89B | 11.31B | 14.80B | 12.16B | 12.80B | 12.99B |
| Net Income Continuous Operations | 7.71B | 3.46B | 6.71B | 6.55B | 5.89B | 7.26B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
